Comment on: In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts

Pediatr Blood Cancer. 2023 Dec;70(12):e30673. doi: 10.1002/pbc.30673. Epub 2023 Sep 13.
No abstract available

Publication types

  • Editorial